Literature DB >> 1150042

Effect of portacaval shunt and arterialization of the liver on bile acid metabolism.

W Horak, A Gangl, J Funovics, G Grabner.   

Abstract

The effect on bile acid clearance of portacaval end-to-side shunt, with and without arterialization of the hepatic portal venous bed, was studied in dogs. Portacaval shunt reduced liver blood flow by 75%, and peripheral serum bile acid concentration rose from 3 to 239 muM. Arterialization maintained total liver blood flow within physiological range and serum bile acid concentration was only 19 muM. Since hepatic bile acid extraction was similar in both groups, bile acid clearance was determined largely by total liver blood flow. The results of this study indicate that hepatic clearance of substances originating from portal blood is impaired in portacaval shunt and can be restored by increasing the arterial blood supply to the liver.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1150042

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  9 in total

1.  Combined measurements of serum bile acid level and splenic volume may be useful to noninvasively assess portal venous pressure.

Authors:  Hiromitsu Hayashi; Toru Beppu; Hirohisa Okabe; Hidetoshi Nitta; Katsunori Imai; Koichi Doi; Akira Chikamoto; Hideo Baba
Journal:  J Gastroenterol       Date:  2012-05-09       Impact factor: 7.527

2.  Portacaval shunt and hyperlipidemia.

Authors:  T E Starzl; C W Putnam; L J Koep
Journal:  Arch Surg       Date:  1978-01

3.  Flow- and pressure-adapted portal arterialization in dogs.

Authors:  H Asakawa; S Kasai; M Mito
Journal:  Jpn J Surg       Date:  1985-07

4.  The effect of portacaval shunt upon hepatic cholesterol synthesis and cyclic AMP in dogs and baboons.

Authors:  A Francavilla; A F Jones; J Benichou; T E Starzl
Journal:  J Surg Res       Date:  1980-01       Impact factor: 2.192

5.  Steatosis, cholestasis, and alkaline phosphatase in alcoholic liver disease.

Authors:  D B McGill
Journal:  Am J Dig Dis       Date:  1978-12

6.  Portacaval shunt in patients with familial hypercholesterolemia.

Authors:  T E Starzl; H P Chase; E H Ahrens; D J McNamara; D W Bilheimer; E J Schaefer; J Rey; K A Porter; E Stein; A Francavilla; L N Benson
Journal:  Ann Surg       Date:  1983-09       Impact factor: 12.969

7.  Morphologic and biochemical changes in dogs after portacaval shunt plus bile fistula or ileal bypass: failure of bile fistula or ileal bypass to prevent hepatocyte atrophy.

Authors:  J S Thompson; K A Porter; N Hayashida; D J McNamara; T S Parker; W J Russell; A Francavilla; T E Starzl
Journal:  Hepatology       Date:  1983 Jul-Aug       Impact factor: 17.425

8.  Influence of portacaval anastomosis on serum and biliary unsulfated bile acid composition in patients with liver cirrhosis.

Authors:  M Angelico; A F Attili; F Bracci; A Di Biase; L Paciscopi; C Puoti; L Capocaccia
Journal:  Dig Dis Sci       Date:  1979-11       Impact factor: 3.199

9.  Cholestatic liver disease associated with diphenylhydantoin therapy. Possible pathogenic importance of altered bile salt metabolism.

Authors:  C B Campbell; C McGuffie; A P Weedon; L W Powell
Journal:  Am J Dig Dis       Date:  1977-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.